Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Europese goedkeuring cannabidiol bij twee ernstige vormen epilepsie
sep 2019 | Epilepsie